Women Health and Gynecology

Welcome Message

We are honored to invite you to the “5^th World Congress on Women Health and Gynecology,” taking place on June 15–16, 2026, in Paris, France, under the theme: “Empowering Women’s Health: Innovation, Research, and Global Equity.”

This distinguished congress will bring together leading clinicians, researchers, academicians, and healthcare professionals dedicated to advancing excellence in women’s health and gynecological care. Through keynote addresses, scientific presentations, and interactive discussions, the program will highlight emerging research, innovative technologies, and evidence-based strategies designed to enhance patient outcomes worldwide.

We look forward to welcoming you for two inspiring days of knowledge exchange, professional collaboration, and collective efforts to strengthen equitable healthcare and shape a healthier future for women across the globe.

Target Audience:

• Obstetricians & Gynecologists
• Women’s Health Specialists
• Reproductive Endocrinologists & Fertility Experts
• Maternal-Fetal Medicine Physicians
• Nurse Practitioners, Midwives & Allied Health Professionals
• Gynecologic Oncologists
• Urogynecologists & Pelvic Floor Specialists
• Public Health Practitioners in Women’s Health
• Clinical Researchers & Scientists
• Healthcare Policymakers & Government Health Officials
• Medical Educators & Academic Faculty
• Healthcare Administrators & Hospital Leaders
• Digital Health & Health Technology Innovators
• Pharmaceutical, Biotech & Medical Device Professionals
• Graduate & Postgraduate Students in Medicine and Health Sciences

About Conference

We are excited to invite you to the “5^th World Congress on Women Health and Gynecology, taking place on June 15–16, 2026, in Paris, France”. This year’s theme, “Empowering Women’s Health: Innovation, Research, and Global Equity,” focuses on integrating the latest scientific breakthroughs, innovative technologies, and collaborative strategies to improve women’s healthcare worldwide.

The congress will gather leading clinicians, researchers, academicians, and healthcare professionals to share knowledge, present cutting-edge research, and discuss emerging trends in gynecology and women’s health. The program features keynote addresses, oral and poster presentations, workshops, panel discussions, and exhibitions, offering a dynamic platform for learning and professional networking.

Attendees will gain insights into new research and technologies, expand their professional networks. Join us in Paris for two impactful days dedicated to shaping the future of women’s health globally.

Why to Attend

Attending the WOMEN HEALTH CONFERENCE 2026 offers an exceptional opportunity to stay at the forefront of women’s healthcare. The congress brings together leading clinicians, researchers, academicians, and industry experts to share knowledge, present innovative research, and discuss emerging trends in gynecology and women’s health. Participants will explore cutting-edge technologies, evidence-based practices, and novel strategies shaping the future of women’s healthcare worldwide.

The event provides a dynamic platform for professional networking, collaboration, and knowledge exchange with global healthcare leaders and policymakers. Attendees can engage in interactive workshops, panel discussions, and oral or poster presentations. Join us in Paris to enhance your expertise, showcase your research, and contribute to advancing women’s health and improving patient outcomes globally.

Sessions & Tracks

Track 1: Women Health

Women’s health across all life stages, emphasizing prevention, early detection, and holistic care. It covers reproductive, metabolic, cardiovascular, bone, and mental health, integrating lifestyle interventions, screenings, and patient education. Emerging strategies highlight personalized care, multidisciplinary approaches, and evidence-based interventions to optimize long-term outcomes, improve quality of life, and empower women to take an active role in maintaining overall health, wellness, and well-being.

Track 2: Gynecology and Obstetrics

Gynecologic and obstetric care, covering reproductive health, maternal-fetal medicine, prenatal and postnatal care, and surgical interventions. It emphasizes evidence-based practices, preventive strategies, and holistic approaches to optimize outcomes for women across all life stages. Emerging innovations include minimally invasive surgery, advanced imaging, and personalized treatment protocols. Multidisciplinary care aims to improve maternal and fetal health, enhance quality of life, and support safe pregnancies and overall women’s health.

Track 3: Gynecologic Oncology

Gynecologic oncology addresses cancers of the female reproductive system, including ovarian, cervical, endometrial, vaginal, and vulvar cancers. Advances in targeted therapies, immunotherapy, and minimally invasive surgery, including robotic-assisted procedures, are improving outcomes and recovery. Early detection through liquid biopsy and HPV screening enhances survival. Ongoing research and clinical trials focus on overcoming resistance, addressing tumor heterogeneity, and applying precision medicine for personalized, effective treatment strategies.

• Ovarian, cervical, and uterine cancers
• Targeted therapies and immunotherapy
• Minimally invasive and robotic surgery
• Early detection and precision medicine

Track 4: Reproductive Endocrinology & Infertility

Reproductive endocrinology and infertility (REI) focuses on diagnosing and treating hormonal and fertility disorders in women and men. Advances in IVF, ICSI, and embryo cryopreservation have improved success rates. Hormonal therapies and minimally invasive surgeries treat conditions like PCOS, endometriosis, and uterine abnormalities. Innovations in genetic screening, fertility preservation, and personalized protocols are expanding reproductive options, optimizing outcomes, reducing risks, and supporting individualized, evidence-based fertility care.

Track 5: Minimally Invasive & Robotic Surgery

Minimally invasive and robotic surgery have revolutionized gynecologic procedures, offering reduced recovery times, lower complication rates, and enhanced precision. These techniques are applied in cancer staging, hysterectomy, myomectomy, and fertility-sparing surgeries. Surgeons increasingly integrate advanced imaging and robotic platforms to optimize outcomes, improve patient safety, and expand surgical options for complex cases.

• Robotic-assisted gynecologic surgery
• Laparoscopic and hysteroscopic techniques
• Enhanced recovery and perioperative care
• Surgical training and simulation

Track 6: Abnormal Uterine Bleeding

Abnormal uterine bleeding (AUB) affects women of all ages and may result from hormonal imbalances, uterine structural issues, or systemic conditions. Diagnosis involves clinical evaluation, imaging, and endometrial assessment. Management includes medical therapies, such as hormonal treatment and antifibrinolytics, and minimally invasive surgeries like hysteroscopy or endometrial ablation. Emerging approaches focus on individualized, fertility-preserving care, precision diagnostics, and multidisciplinary strategies to improve outcomes and quality of life.

Track 7: Artificial Intelligence in Gynecology

Artificial intelligence (AI) is revolutionizing gynecology by improving diagnostics, treatment planning, and patient care. Applications include predictive algorithms for cancer detection, fertility outcome modeling, robotic-assisted surgery guidance, and personalized therapy recommendations. Machine learning and data analytics enhance accuracy, efficiency, and clinical decision-making. Emerging research focuses on integrating AI with imaging, genomics, and electronic health records to optimize outcomes, minimize errors, and advance precision medicine, paving the way for smarter, patient-centered gynecologic care worldwide.

Track 8: Pediatric Gynecology

Pediatric gynecology addresses reproductive health in girls and adolescents, including congenital anomalies, menstrual disorders, hormonal imbalances, and puberty-related concerns. Early diagnosis and age-appropriate care are vital for physical and reproductive well-being. Management includes medical therapies, minimally invasive surgery, and preventive counseling. Emerging strategies focus on patient-centered, multidisciplinary care, with advances in imaging, genetics, and personalized treatment improving outcomes and supporting healthy development and long-term reproductive health for young patients.

• Congenital reproductive anomalies
• Adolescent menstrual and hormonal disorders
• Minimally invasive pediatric gynecologic surgery
• Fertility preservation and counselling

Track 9: Adolescent Gynecology & Puberty Disorders

Adolescent gynecology focuses on the reproductive health of teenagers, addressing menstrual irregularities, hormonal imbalances, puberty-related disorders, and sexual health concerns. Early evaluation and age-appropriate management are critical for physical, emotional, and reproductive well-being. Care includes medical therapy, counseling, and minimally invasive interventions. Emerging approaches emphasize patient-centered, multidisciplinary strategies, education, and preventive care, aiming to support healthy development, optimize long-term reproductive outcomes, and empower adolescents with knowledge and access to proper gynecologic care.

Track 10: Menstrual Cycle Disorders

Menstrual cycle disorders, including dysmenorrhea, premenstrual syndrome (PMS), polycystic ovary syndrome (PCOS), and menstrual irregularities. It focuses on accurate diagnosis, hormonal evaluation, and individualized management through medical therapy, lifestyle interventions, and minimally invasive procedures. Emerging research emphasizes patient-centered care, early intervention, and multidisciplinary strategies to improve quality of life, regulate cycles, and optimize reproductive health in women across all age groups.

• Dysmenorrhea management
• PMS and hormonal therapy
• PCOS diagnosis and treatment
• Menstrual irregularities and lifestyle interventions

Track 11: Breast Health & Cancer

Breast health, including cancer prevention, screening, genetic risk assessment, and early interventions. It covers accurate diagnosis, risk stratification, and personalized management using imaging, genetic counseling, lifestyle modifications, and minimally invasive procedures. Emerging research focuses on early detection, precision treatment, patient education, and supportive care. Multidisciplinary approaches aim to improve outcomes, enhance quality of life, and promote long-term breast health for women across all ages.

Track 12: Genetic Disorders & Personalized Medicine

Genetic disorders and personalized medicine in gynecology, including BRCA mutations, hereditary cancer syndromes, and precision care approaches. It emphasizes genetic testing, risk assessment, counseling, and individualized treatment planning. Emerging strategies integrate genomics, targeted therapies, and multidisciplinary collaboration to improve outcomes, enable early interventions, and provide patient-centered care, supporting prevention, early detection, and personalized management of hereditary gynecologic conditions.

Track 13: Gestational Diabetes

Gestational diabetes focuses on glucose intolerance developing during pregnancy, affecting maternal and fetal health. Early diagnosis through screening, monitoring, and blood glucose management is essential. Care includes medical nutrition therapy, lifestyle interventions, and insulin or oral medications when needed. Emerging research emphasizes individualized treatment, risk reduction, and multidisciplinary management to prevent complications such as preeclampsia, macrosomia, and long-term metabolic risks for both mother and child.

• Screening and diagnosis
• Nutritional and lifestyle management
• Pharmacologic interventions
• Maternal and fetal risk reduction

Track 14: Menopause & Aging Women’s Health

Menopause and health challenges in aging women, including hormonal changes, metabolic health, bone density, and mental well-being. Management strategies include hormone replacement therapy, lifestyle interventions, preventive care, and multidisciplinary support. Emerging approaches emphasize individualized care, risk assessment, and patient education to improve quality of life, prevent chronic conditions, and promote healthy aging in women across physical, mental, and reproductive health domains.

Track 15: Sexually Transmitted Infections (STIs)

Sexually transmitted infections (STIs) in women require prevention, accurate diagnosis, and effective management. This includes bacterial, viral, and parasitic infections, with a focus on early detection, routine screening, and evidence-based treatment. Emerging strategies involve vaccination, patient education, partner management, and public health initiatives. Multidisciplinary approaches aim to reduce complications, prevent transmission, and support reproductive and overall sexual health, ensuring comprehensive care and improved well-being for women across all ages and life stages.

Track 16: Maternal & Fetal Care

Maternal and fatal Care, emphasizing high-risk pregnancies, prenatal monitoring, and fatal therapy. It covers early detection of complications, individualized care plans, and multidisciplinary management to optimize outcomes for both mother and baby. Emerging strategies include advanced imaging, genetic screening, and evidence-based interventions to improve maternal-fetal safety, prevent adverse events, and support healthy pregnancy and delivery

• High-risk pregnancy management
• Prenatal screening and monitoring
• Fetal therapy and interventions
• Maternal-fetal risk reduction strategies

Track 17: Digital Health & Telemedicine in Women’s Care

Digital health and telemedicine innovations in women’s care, including AI-driven tools, remote monitoring, mobile health apps, and virtual care models. It focuses on improving access, patient engagement, and personalized care through technology. Emerging strategies integrate digital solutions with clinical workflows to enhance diagnostics, monitor chronic conditions, support preventive care, and provide patient education, empowering women to manage their health effectively across all life stages.

Track 18: Prenatal Diagnostics

Prenatal diagnostics to ensure maternal and fetal health. It covers non-invasive and invasive screening methods, advanced imaging, genetic testing, and biomarker analysis for early detection of congenital anomalies and pregnancy complications. Personalized care plans and multidisciplinary management optimize outcomes. Emerging approaches integrate precision medicine, advanced ultrasound, and molecular diagnostics to improve accuracy, guide interventions, and support informed decision-making for expecting mothers and healthcare providers.

Track 19: Endometriosis & Adenomyosis

Endometriosis & Adenomyosis focuses on the diagnosis, management, and treatment of endometriosis and adenomyosis, common gynecologic conditions affecting fertility and quality of life. Care includes medical therapy, hormonal management, minimally invasive surgery, and pain control strategies. Emerging research emphasizes individualized treatment, fertility preservation, and multidisciplinary approaches to optimize outcomes, reduce recurrence, and improve physical and emotional well-being for affected women.

• Hormonal and medical management
• Minimally invasive surgical techniques
• Pain management strategies
• Fertility preservation and multidisciplinary care

Track 20: Integrative & Complementary Medicine

Integrative and complementary approaches in women’s health, combining conventional medicine with therapies such as nutrition, acupuncture, yoga, mindfulness, and herbal interventions. It emphasizes holistic, patient-centered care to enhance physical, mental, and reproductive well-being. Emerging strategies focus on evidence-based practices, multidisciplinary collaboration, and personalized care plans to improve outcomes, support wellness, reduce stress, and promote overall quality of life for women.

Track 21: Planning and Contraceptive Methods

Planning and contraceptive options for women, emphasizing informed decision-making, safety, and reproductive autonomy. It covers hormonal methods, intrauterine devices, barrier methods, permanent options, and emerging technologies. Counseling and personalized care are key to optimizing outcomes and preventing unintended pregnancies. Multidisciplinary approaches integrate patient education, public health initiatives, and clinical strategies to support reproductive health, family planning goals, and overall well-being across different life stages.

Track 22: Clinical Trials & Translational Research

Clinical trials and translational research in women’s health, bridging laboratory discoveries with patient care. It covers study design, novel therapeutics, biomarker development, and evidence-based interventions. Emerging strategies emphasize personalized medicine, multicenter collaboration, and innovative methodologies to accelerate the translation of research into practice. The goal is to improve outcomes, optimize treatments, and advance women’s health through scientific innovation.

Track 23: Global Health Equity

Global Health Equity focuses on policies and strategies to ensure equitable access to women’s healthcare worldwide. It addresses disparities in maternal health, reproductive services, preventive care, and chronic disease management. Emerging approaches emphasize community-based interventions, global partnerships, health education, and evidence-based policies to improve access, quality, and outcomes. Multidisciplinary collaboration aims to reduce inequities and promote comprehensive, sustainable, and inclusive women’s health care.

• Maternal and reproductive health equity
• Community-based health initiatives
• Global health policy and advocacy
• Access to preventive and chronic care

Market Analysis

The women’s health industry is experiencing steady global growth, fueled by stronger policy frameworks, rising awareness, and rapid technological innovation. International bodies such as the World Health Organization and regulatory authorities like the U.S. Food and Drug Administration play vital roles in ensuring safety, quality standards, and improved access to healthcare services for women. Government-led initiatives in maternal health and breast cancer screening have significantly enhanced early detection and survival rates, reinforcing the shift toward preventive care.

The market is projected to expand from US$ 41.3 billion in 2023 to US$ 66 billion by 2033, growing at a 4.8% CAGR. Increased venture capital and private equity investments—particularly in fertility solutions, telemedicine, wearable devices, and AI-driven diagnostics—highlight strong confidence in the sector’s innovation potential. These technologies are transforming healthcare delivery by making it more personalized, accessible, and data-driven.

Gynecological conditions remain the leading segment, accounting for over 37% of market share due to improved diagnostic tools and treatment options. Mental health, cardiovascular care, and maternal services are also gaining prominence. While adult women represent the largest age group, growing attention is being directed toward adolescent and elderly women. Despite progress, challenges such as limited healthcare access and gender bias in research persist, emphasizing the need for continued investment and inclusive healthcare policies 

Past Conference

We extend our heartfelt gratitude to all Keynote Speakers, Session Speakers, Organizing Committee Members, Delegates, Students, and Supporting Associations for contributing to the outstanding success of the Women Health Conference 2025. Your active participation and commitment helped shape the conference into a dynamic international platform dedicated to advancing research, innovation, and clinical excellence in women’s health and gynecology.

With attendees representing more than 25 countries, the conference brought together renowned academicians, clinicians, researchers, healthcare professionals, and industry leaders who exchanged valuable knowledge and practical expertise. Guided by the theme “Transforming Women's Health with Innovation and Empowerment” the event promoted meaningful collaboration, encouraged patient-centered strategies, and highlighted emerging trends shaping the future of women’s healthcare worldwide.

The conference was inaugurated with the esteemed presence of distinguished keynote and plenary speakers who addressed current challenges and breakthrough developments in obstetrics, gynecology, reproductive medicine, and women’s wellness. Their insightful presentations inspired engaging discussions, scientific exchange, and interdisciplinary networking throughout the program.

The supporting journals for the conference included:
Journal of Womens Health, Issues and Care | Critical Care Obstetrics and Gynecology | Reproductive System & Sexual Disorders: Current Research

Building on the remarkable success of the 2025 edition, we are pleased to announce the 5^th World Congress on Women Health and Gynecology, scheduled for June 15–16, 2026 in Paris, France. This upcoming congress will continue to serve as a premier global forum for sharing groundbreaking research, exploring innovative clinical practices, and strengthening international collaborations dedicated to improving women’s health outcomes worldwide.

Participation/Presentation Options

Oral Presentation: Oral presentations at WOMEN HEALTH CONFERENCE 2026 are open to research-based, theoretical, clinical, professional, and practice-oriented topics related to women’s health, gynecology, obstetrics, reproductive medicine, and public health. Individuals with lived experiences are also welcome to share insights that can positively impact clinical practice and community care.

• Speaker Slot: 30 minutes (20–25 minutes presentation + Q&A session)
• Keynote Slot: 40–45 minutes, followed by discussion

Workshop Presentation: Workshops will focus on advanced clinical approaches, innovative techniques, hands-on demonstrations, and interactive learning in women’s healthcare.

• Duration: 45–50 minutes
• Team presentations are encouraged.
• Group presenters may be eligible for special registration benefits.

Poster Presentation: The Poster Competition at WOMEN HEALTH CONFERENCE 2026 encourages students, early-career researchers, and healthcare professionals to present original research.

• 20–25 minutes presentation (including Q&A)
• Evaluation by a judging panel
• Posters must be printed (1m x 1m dimensions)

This competition provides an excellent opportunity to gain visibility, receive feedback, and strengthen interdisciplinary research skills.

Webinar Presentation: For participants unable to attend in person, the conference offers a virtual presentation option. Presenters may submit pre-recorded video presentations to be featured during the official webinar sessions.

E-Poster Presentation: E-Posters are available for remote participants and will be displayed on the official conference platform. Accepted abstracts will be published in the conference proceedings with DOI indexing.

Exhibition Opportunities: The conference will feature a dedicated Exhibition Pavilion, providing commercial and non-commercial organizations an opportunity to showcase innovations, services, and technologies in women’s healthcare.

Potential Exhibitors Include:

• Pharmaceutical Companies
• Clinical Research Organizations
• Medical Device & Equipment Manufacturers
• Hospitals and Specialty Clinics
• Healthcare Consultants
• Gynecologists and Obstetricians
• Academic & Research Institutions
• Startups and Business Delegates

This exhibition offers valuable networking opportunities and enhanced brand visibility within the global women’s health community.

For exhibitor inquiries: meevents@memeetings.com

Advertisement: The official conference program serves as an essential resource for all attendees. Advertising within the program is an effective way to promote your services and gain lasting exposure.

For advertisement opportunities and pricing details, contact:
meevents@memeetings.com

Communication Guidelines

To ensure smooth communication:

Please add meevents@memeetings.com to your safe sender list.

• If you do not receive confirmation within 48 hours of registration or inquiry, kindly contact the conference coordinator.
• Always check your spam/junk folder before following up.

Group Registration Discounts

Discounted rates are available for group registrations. For eligibility criteria and pricing, please contact:
meevents@memeetings.com

Important Registration Information

To ensure efficient coordination:

• Include your mobile phone number in your registration form and abstract submission.
• This allows us to provide timely updates and important notifications.

For all general inquiries, please contact:
meevents@memeetings.com

Abstract Submission Guidelines

1. Abstracts must be submitted through the official Abstract Submission link.
2. Abstracts should be written in English (250–300 words), along with a presenter biography (100–120 words).
3. Submissions are welcome across all areas of women’s health, gynecology, obstetrics, reproductive medicine, maternal health, oncology, and public health.
4. Presenting authors must provide: Full Name, Affiliation (Department, Institution/Hospital, Country), Phone Number, Email Address, and Photograph.
5. Co-authors must include full names and institutional affiliations.
6. All abstracts will be reviewed by the Conference Review Committee.
7. Accepted presenters must complete registration and pay the applicable conference fee.

Please ensure that your abstract title and affiliation details are accurate, as they will appear exactly as submitted in the final program and conference proceedings. Registration must be completed upon acceptance to confirm participation.

Visa Guidelines

WOMEN HEALTH CONFERENCE 2026 organizing committee hereby reiterates that we are NOT involved in VISA processing. We can assist by providing supporting documents like a Letter of invitation, Letter of Abstract Acceptance and Registration Payment Receipt.

You may be required to submit additional documents along with these documents to the embassy.

Letter of Invitation: The official Letter of Invitation is proof that your submitted paper and registration application are accepted by the conference committee board. It will be stated in English and may help you with your visa application.

Only registered participants will get an official letter of invitation

Attendees need to finish Registration & Authenticated information submission to get an official letter of invitation [i.e., Passport (Scan copy), DOB, Mobile Number, Physical Address and Photograph].

For more information Please Contact us at:   meevents@memeetings.com

Official Letters of Invitation will be provided only to attend the conference.